Practice Offers Telemedicine!
Skip to main content

Altaviva Test

What is Altaviva?

Altaviva is an advanced therapy designed to help treat symptoms of overactive bladder (OAB), including urge urinary incontinence, frequent urination, and sudden, difficult-to-control urges to urinate. It uses gentle neuromodulation technology to improve communication between your bladder and the nerves that control it.

How does Altaviva work?

Your bladder and brain constantly communicate through a network of nerves that control when your bladder stores urine and when it's time to empty. In people with an overactive bladder, these nerve signals can become disrupted, causing the bladder to contract before it's full.

Altaviva delivers gentle stimulation to the nerves involved in bladder control, helping normalize these signals and improve bladder function. By restoring healthier communication between the bladder and nervous system, many patients experience fewer urgent trips to the bathroom and improved bladder control.

Your provider will explain how the treatment is performed, answer your questions, and create a care plan tailored to your individual needs.

What conditions does Altaviva treat?

Altaviva is primarily used to treat symptoms associated with an overactive bladder, including:

  • Urge urinary incontinence
  • Sudden, intense urges to urinate
  • Frequent urination during the day
  • Waking multiple times at night to urinate (nocturia)

If these symptoms interfere with your work, sleep, travel, or everyday activities, Altaviva may provide meaningful relief.

  1. Stewart WF, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-336.
  2. US Census Bureau 2020. US adult and under-age-18 populations: 2020 census. https://www.census.gov/library/visualizations/interactive/adult-and-under-the-age-of-18-populations-2020-census.html. Accessed June 20, 2022.
  3. Ditah I, Devaki P, Luma HN, et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol. 2014;12:636-643.
  4. Whitehead WE, Borrud L, Goode PS, et al. Fecal Incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137(2):512-517.

Dicover the Altaviva™ therapy advantage

The only tibial neuromodulation device...

Icon

Full-body MRI ready from the start with therapy on1-3

Icon

15-year Overdrive™ battery technology‡,2,4,5

Icon

Same-day therapy activation2,4,5

† Under certain conditions; see approved labeling for details.

‡ Based on clinical and bench testing for expected therapy settings.

Many patients choose Altaviva because it offers several potential benefits, including:

  • Reduced urinary urgency and frequency
  • Fewer episodes of urge urinary incontinence
  • Improved bladder control
  • A minimally invasive approach
  • Personalized treatment based on your symptoms and response

Results vary from person to person, and your provider will monitor your progress to help you achieve the best possible outcome.

More than 450,000
patients have trusted Medtronic technologies for bladder and bowel control

Who is a good candidate for Altaviva?

You may be a good candidate for Altaviva if you:

  • Have been diagnosed with overactive bladder or urge urinary incontinence
  • Continue to experience symptoms despite lifestyle changes or medications
  • Prefer a minimally invasive treatment option
  • Want an alternative to more invasive surgical procedures

The team at Pacific Northwest Urology Specialists performs a comprehensive evaluation to determine whether Altaviva is the most appropriate treatment for your condition and goals.

Icon

Doctor discussion guide

Are you planning to talk to your doctor about Altaviva implant for UUI?

This guide will help you organize your thoughts to help maximize your appointment, and with the help of your doctor decide if this therapy is suitable for you.

Download a printable PDF

Our Locations

Choose your preferred location